Literature DB >> 3932603

The case for combination chemotherapy in the treatment of advanced ovarian cancer.

R F Ozols.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3932603     DOI： 10.1200/JCO.1985.3.11.1445

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.

Authors:  E M Rankin; L Mill; S B Kaye; R Atkinson; L Cassidy; J Cordiner; D Cruickshank; J Davis; I D Duncan; W Fullerton
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

2.  A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy.

Authors:  Lauren E Ta; James D Schmelzer; Allan J Bieber; Charles L Loprinzi; Gary C Sieck; Jill D Brederson; Philip A Low; Anthony J Windebank
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

3.  Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli.

Authors:  Lauren E Ta; Philip A Low; Anthony J Windebank
Journal:  Mol Pain       Date:  2009-02-26       Impact factor: 3.395
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.